Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Acrocephalosyndactylia × erdafitinib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Neoplasms 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1 Acrocephalosyndactylia 1

Interventions

infigratinib 2 pemigatinib 1 exemestane 1 erdafitinib 1 Fulvestrant 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05567185 2026-03-13

TAR-210

Janssen Pharmaceutical K.K.

Phase 1 Active not recruiting

Acrocephalosyndactylia, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡